期刊文献+

桂皮醛对口腔鳞状细胞癌细胞抑制作用的体外研究 被引量:1

Effects of cinnamaldehyde on oral squamous carcinoma cell in vitro
下载PDF
导出
摘要 目的体外研究中药桂皮醛对口腔鳞状细胞癌细胞增殖的抑制作用。方法以3种人口腔鳞状细胞癌细胞株为研究对象,采用噻唑蓝(MTT)比色法观察桂皮醛不同质量浓度、不同作用时间下对各细胞株增殖的影响。应用SPSS 16.0软件对数据进行方差分析。结果与空白对照组相比,256、128、64、32 mg.L-1质量浓度组的桂皮醛对人口腔鳞状细胞癌细胞的增殖表现出明显抑制作用,且抑制作用随着药物质量浓度的升高而加强,呈现明显的剂量-效应关系。药物作用时间24 h时,作用质量浓度16 mg.L-1时,对人舌鳞状细胞癌Tca8113细胞株抑瘤率达到58.33%;作用质量浓度为32 mg.L-1时对KB细胞及人颊黏膜鳞状细胞癌BCaCD885细胞株的抑制率分别为66.08%、76.61%,其抑制率随着药物作用时间的延长而增加。结论桂皮醛对口腔鳞状细胞癌细胞增殖的抑制作用与质量浓度和作用时间有关,中、高浓度的桂皮醛对3种人口腔鳞状细胞癌细胞增殖均具有明显的抑制作用,在一定程度上肯定了桂皮醛的抗肿瘤作用。 Objective To investigate the inhibiting in vitro effect of cinnamaldehyde on human oral squamous carcinoma cell. Methods Using methyl thiazolyl tetrazolium (MTY) to assay the effect of cinnamaldehyde on hu- man tongue carcinoma cell lines(Tca8113), human buccal squamous carcinoma cell lines(BCaCD885), human oral epithelial carcinoma KB cell in different concentrations. The final concentrations of cinnamaldehyde were from 8 to 256 mg.L-1, respectively. The cells were cultured in different concentrations, and the cinnamaldehyde continuously contacted with the cells for 24, 48 and 72 h, respectively, we compared the efficacy of cinnamaldehyde in dif- ferent concentration groups during different time quantum. Differences between data obtained were statistically analyzed using analysis of variance (ANOVA) in SPSS 16.0. Results When the concentration of cinnamicaldehyde were from 32 to 256 mg.L-1, it had a significant inhibition on the proliferation of oral cancer cells in vitro, and with a increasing concentration of cinnamicaldehyde, the efficacy of inhibition became more significant, which showed an obvious dosage-efficacy relationship. When cinnamaldehyde acted 24 hours or its concentration was 16mg.L-1, the inhibition rate was 58.33% for the human tongue squamous cell carcinoma cell line Tca8113; when the concentration was on the level of 32 mg.L-1, the inhibition rate were 66.08%, 76.61% respectively for human oral epithelial carcinoma KB cell and human buccal squamous carcinoma cell BCaCD885, respectively. Conclusion In the medium-high (from 32 to 256 mg.L-1) concentrations of cinnamaldehyde showed remarkable cytostatic activity in terms of inhibition the proliferation of oral squamous carcinoma epithelial cell.
出处 《国际口腔医学杂志》 CAS 2013年第1期10-13,共4页 International Journal of Stomatology
关键词 桂皮醛 口腔鳞状细胞癌细胞 噻唑蓝 cinnamaldehyde oral squamous carcinoma epithelial cell: methyl thiazolyl tetrazolium
  • 相关文献

参考文献8

  • 1黄敬群,王四旺.桂皮醛药理研究进展[J].中国新医药,2004,3(9):61-63. 被引量:33
  • 2Moon KH, Pakc MY. Cytotoxicity of cinnamaldehyde onleukemia LI1210 cells [J]. Drug Chem Toxicol, 1983,6(6):521-535.
  • 3Kwon BM, Lee SH, Choi SU, et al. Synthesis and invitro cytotoxicity of cinnamaldehydes to human solid tu-mor cells[J]. Arch Pharm Res, 1998, 21 (2) : 147-152.
  • 4Imai T, Yasuhara K, Tamura T, et al. Inhibitory effectsof cinnamaldehyde on 4- (methylnitrosamino) -1 - (3-pyri-dyl) -1-butanone-induced lung carcinogenesis in ras H2micefj]. Cancer Lett, 2002, 175(1): 9-16.
  • 5Wu SJ, Ng LT, Lin CC. Cinnamaldehyde-induced apop-tosis in human PLC/PRF/5 cells through activation of theproapoptotic Bcl-2 family proteins and MAPK pathway[J].Life Sci,2005, 77(8):938-951.
  • 6Ka H, Park HJ, Jung HJ, et al. Cinnamaldehyde inducesapoptosis by ROS -mediated mitochondrial permeabilitytransition in human promyelocytic leukemia HL-60 cells[J]. Cancer Lett, 2003, 196(2):143-152.
  • 7肖艳,李俊东,史泓浏,刘继红,冯艳玲,李孟达.MTT法体外药敏实验预测宫颈癌细胞药物敏感性的初步探讨[J].癌症,2007,26(4):386-389. 被引量:17
  • 8Sargent JM. The use of the MTT assay to study drug re-sistance in fresh tumour samples[J]. Recent Results CancerRes, 2003, 161(1):13-25.

二级参考文献10

  • 1Burton J D.The MTT assay to evaluate chemosensitivity[J ].Methods Mol Med,2005,110(1):69-78.
  • 2Scheithauer W,Clark G M,Salmon S E,et al.Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man[J].Cancer Treat Rep,1986,70(12):1379-1382.
  • 3Parkin D M,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 4Moore D H.Treatment of stage IB2 (bulky) cervical carcinoma[J].Cancer Treat Rev,2003,29(5):401-406.
  • 5Sultana H,Kigawa J,Kanamori Y,et al.Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer[J].Ann Oncol,2003,14(2):214-219.
  • 6Sargent J M.The use of the MTT assay to study drug resistance in fresh tumour samples[J].Recent Results Cancer Res,2003,161 (1):13-25.
  • 7Taylor C G,Sargent J M,Elgie A W,et al.Chemosensitivity testing predicts survival in ovarian cancer[J].Eur J Gynaecol Oncol,2001,22(4):278-282.
  • 8Tinker A V,Bhagat K,Swenerton K D,et al.Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma:the British Columbia Cancer Agency experience[J].Gynecol Oncol,2005,98(1):54-58.
  • 9Rose P G,Blessing J A,Gershenson D M,et al.Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix:a gynecologic oncology group study[J].J Clin Oncol,1999,17(9):2676-2680.
  • 10Duenas-Gonzalez A,Lopez-Graniel C,Gonzalez-Enciso A,et al.A phase Ⅱ study of multimodality treatment for locally advanced cervical cancer:neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation[J].Ann Oncol,2003,14(8):1278-1284.

共引文献48

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部